Clinical Trial Update: Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine-containing regimens as preoperative chemotherapy for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Non Small Cell Lung | Phase 2 | Status: COMPLETED